CVE-2017-13993

Description

An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient.

Categories

7.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.15%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: n/a i-SENS, Inc. SmartLog Diabetes Management Software
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-01 us government resource third party advisory patch
http://www.securityfocus.com/bid/100659 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-13993?
CVE-2017-13993 has been scored as a high severity vulnerability.
How to fix CVE-2017-13993?
To fix CVE-2017-13993, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-13993 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-13993 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-13993?
CVE-2017-13993 affects n/a i-SENS, Inc. SmartLog Diabetes Management Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.